Klotho Neurosciences (KLTO) Stock Statistics & Valuation Metrics

Klotho Neurosciences has a market cap or net worth of $66.93M. The enterprise value is $44.74M.

Klotho Neurosciences has 52,703,070 shares outstanding. The number of shares has decreased by -2.65% in one year.

Klotho Neurosciences’s return on equity (ROE) is -5.19 and return on invested capital (ROIC) is -373.94%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Klotho Neurosciences had revenue of 0.00 and earned -6.15M in profits. Earnings per share was -0.32.

In the last 12 months, operating cash flow was -3.57M and capital expenditures 0.00, giving a free cash flow of -3.57M billion.

Klotho Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Klotho Neurosciences upcoming earnings date is ―, ―.

Klotho Neurosciences as a current ratio of 0.13, with Debt / Equity ratio of 276.80%

In the past 12 months, Klotho Neurosciences has paid 0.00 in taxes.

Klotho Neurosciences EV to EBITDA ratio is -1.65, with an EV/FCF ratio of -3.11.

Klotho Neurosciences has $565.87K in cash and marketable securities with $1.77M in debt, giving a net cash position of $1.20M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Klotho Neurosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―